Evome Medical Technologies (LNDZF) Short Interest Ratio & Short Volume → Boost your retirement with these AI payouts (From InvestorPlace) (Ad) Free LNDZF Stock Alerts $0.21 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Evome Medical Technologies Short Interest DataCurrent Short Interest200 sharesPrevious Short Interest8,200 sharesChange Vs. Previous Month-97.56%Dollar Volume Sold Short$38.00Short Interest Ratio0.0 Days to CoverLast Record DateMarch 15, 2024Today's Trading Volume0 sharesAverage Trading Volume7,738 sharesToday's Volume Vs. Average0% Short Selling Evome Medical Technologies ? Sign up to receive the latest short interest report for Evome Medical Technologies and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLNDZF Short Interest Over TimeLNDZF Days to Cover Over TimeLNDZF Percentage of Float Shorted Over Time Ad Stansberry ResearchEverybody laughed when he recommended Netflix"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. Evome Medical Technologies Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/2024200 shares $38.00 -97.6%N/A0 $0.19 2/29/20248,200 shares $1,107.82 No ChangeN/A16.4 $0.14 2/15/20248,200 shares $1,312.00 +4,000.0%N/A2.4 $0.16 1/15/20245,200 shares $832.00 No ChangeN/A0.5 $0.16 12/31/20235,200 shares $788.32 No ChangeN/A14.7 $0.15 12/15/20235,200 shares $520.00 +2,500.0%N/A1.2 $0.10 Get the Latest News and Ratings for LNDZF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evome Medical Technologies and its competitors with MarketBeat's FREE daily newsletter. 11/30/2023200 shares $35.78 No ChangeN/A0.1 $0.18 11/15/2023200 shares $31.08 No ChangeN/A0 $0.16 10/31/2023200 shares $31.08 -90.9%N/A0.2 $0.16 10/15/20232,200 shares $352.00 +1,000.0%N/A0.2 $0.16 9/30/2023200 shares $40.00 No ChangeN/A0 $0.20 9/15/2023200 shares $32.20 No ChangeN/A0.3 $0.16 8/31/2023200 shares $32.20 No ChangeN/A0.1 $0.16 8/15/2023200 shares $41.18 No ChangeN/A0 $0.21 7/31/2023200 shares $60.00 -86.7%N/A0 $0.30 7/15/20231,500 shares $320.10 No ChangeN/A0.5 $0.21 6/30/20231,500 shares $282.90 -40.0%N/A0.1 $0.19 6/15/20232,500 shares $500.00 No ChangeN/A0.1 $0.20 3/31/20234,600 shares $1,242.00 No ChangeN/A1 $0.27 2/28/202314,600 shares $4,771.28 No ChangeN/A1.2 $0.33 12/15/20221,900 shares $703.00 No ChangeN/A0.2 $0.37 11/15/202294,200 shares $36,587.28 No ChangeN/A0 $0.39 10/31/202294,200 shares $36,587.28 +3.3%N/A17.8 $0.39 10/15/202291,200 shares $36,480.00 -1.1%N/A36.5 $0.40 9/30/202292,200 shares $42,015.54 +1.0%N/A8.6 $0.46 9/15/202291,300 shares $43,824.00 -18.0%N/A25.4 $0.48 8/31/2022111,300 shares $55,816.95 +62.7%N/A5.9 $0.50 8/15/202268,400 shares $41,710.32 +10.7%N/A1.3 $0.61 7/31/202261,800 shares $37,698.00 +6.2%N/A6.6 $0.61 7/15/202258,200 shares $34,774.50 +1.4%N/A52.9 $0.60 6/30/202257,400 shares $31,518.34 +0.2%N/A19.8 $0.55 6/15/202257,300 shares $33,884.36 -28.5%N/A13.6 $0.59 5/31/202280,100 shares $41,037.63 +220.4%N/A6.2 $0.51 5/15/202225,000 shares $13,750.00 No ChangeN/A2.3 $0.55 4/30/202225,000 shares $15,942.50 +6.4%N/A1.4 $0.64 4/15/202223,500 shares $14,864.22 +11.9%N/A5.5 $0.63 3/31/202221,000 shares $9,450.00 -6.7%N/A4.8 $0.45 3/15/202222,500 shares $9,389.25 -43.3%N/A11.3 $0.42 2/28/202239,700 shares $17,468.00 -5.9%N/A5 $0.44 2/15/202242,200 shares $16,036.00 -17.4%N/A2.6 $0.38Warren Buffett's "mystery stock" (Ad)WARNING: Read This Before the Next Fed Meeting Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion. This Wall Street millionaire just stepped forward with all the details, and how it could make some 1/31/202251,100 shares $24,323.60 +12.1%N/A1.8 $0.48 LNDZF Short Interest - Frequently Asked Questions What is Evome Medical Technologies' current short interest? Short interest is the volume of Evome Medical Technologies shares that have been sold short but have not yet been covered or closed out. As of March 15th, traders have sold 200 shares of LNDZF short. Learn More on Evome Medical Technologies' current short interest. Is Evome Medical Technologies' short interest increasing or decreasing? Evome Medical Technologies saw a decline in short interest in March. As of March 15th, there was short interest totaling 200 shares, a decline of 97.6% from the previous total of 8,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Cummins Inc. ($8.93 billion), Canadian Natural Resources Limited ($7.79 billion), Super Micro Computer, Inc. ($4.31 billion), T-Mobile US, Inc. ($4.00 billion), General Motors ($3.36 billion), Occidental Petroleum Co. ($3.10 billion), Charter Communications, Inc. ($2.92 billion), Coinbase Global, Inc. ($2.74 billion), Tractor Supply ($2.72 billion), and Moderna, Inc. ($2.31 billion). View all of the most shorted stocks. What does it mean to sell short Evome Medical Technologies stock? Short selling LNDZF is an investing strategy that aims to generate trading profit from Evome Medical Technologies as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Evome Medical Technologies? A short squeeze for Evome Medical Technologies occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LNDZF, which in turn drives the price of the stock up even further. How often is Evome Medical Technologies' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LNDZF, twice per month. The most recent reporting period available is March, 15 2024. More Short Interest Resources from MarketBeat Related Companies: AIMDW Short Interest Data CLLKF Short Interest Data BBLGW Short Interest Data LCDX Short Interest Data CMXC Short Interest Data CLVSF Short Interest Data CHEOF Short Interest Data WILLF Short Interest Data DGWPF Short Interest Data EMED Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:LNDZF) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingDoes this make you sick?Allegiance GoldThis Apple-like Innovator is Revolutionizing HealthcareWall Street Star**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsThis Could be Your “Big Money” AI MomentInvestorPlace